Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

aloe vera 20%, zingiber officinale 5%, nauclea latifolia 20%, occimum gratissimum 10%

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

barbados aloe 10%, vitellaria paradaxa 20%, wax apis meliferia 10%

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

utellara paradox 3%, eucaliptus globulus 1%, barbados aloe 2%, zingiber officinale 2%, allium sativum 1%, garcinia kola 1%, elaeis guineensis 40%, apis mellifora 50%

Philippines - English - FDA (Food And Drug Administration)

bliss pharma distribution and consultancy corp.; distributor: bliss pharma distribution and consultancy corp. - levofloxacin (as hemihydrate) - film-coated tablet - 500mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - diluent for injection - see ingredients - 10 ml water for injections 10 ml

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - injection - see ingredients - each 10 ml solution contains potassium chloride 1,5 g

Philippines - English - FDA (Food And Drug Administration)

bliss pharma distribution and consultancy corp.; distributor: bliss pharma distribution and consultancy corp. - levofloxacin (as hemihydrate) - film-coated tablet - 500 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

remedial sciences international pty ltd - nicotinamide, quantity: 50 mg; centella asiatica, quantity: 12.5 mg (equivalent: centella asiatica, qty 50 mg); ginkgo biloba, quantity: 1 mg (equivalent: ginkgo biloba, qty 50 mg); crataegus monogyna, quantity: 25 mg (equivalent: crataegus monogyna, qty 100 mg); tilia x vulgaris, quantity: 12.5 mg (equivalent: tilia x vulgaris, qty 50 mg); d-alpha-tocopheryl acid succinate, quantity: 85 mg; selenium, quantity: 50 microgram - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; sodium lauryl sulfate; crospovidone; colloidal anhydrous silica; magnesium stearate; povidone; maltodextrin

Australia - English - Department of Health (Therapeutic Goods Administration)

au remedials -

Australia - English - Department of Health (Therapeutic Goods Administration)

au remedials - 12837 - orthosis, - brace belt, designed to be worn around the waist over light clothing to provide support. a device intended to be used to support, align, prevent, or correct bodily deformities/injuries, to improve the function of movable parts of the body and to relieve lower back related pains.